glp 1 qualification GLP-1 Eligibility Beyond BMI: Clinical Guidelines & Biomarkers – PlexusDx HINES CLINICAL GLP-1 WEIGHT MANAGEMENT

The FDA defines a compounded drug as essentially a copy if it contains the same active pharmaceutical ingredient (API) and can be used by the same route of administration as the approved drug

Since the newest drugs have proven so effective both at helping people lose weight and preventing other health problems doctors and policymakers want to expand access to GLP-1 medications

Some notice increased energy as their blood sugars stabilize and they start to feel healthier

Submitted: August 11, 2024

Parenteral administration is expected to dominate the market, accounting for 80% of the market share in 2026, as GLP-1 Receptor Agonists are commonly administered via injections for better absorption and efficacy